A carregar...
Immunogenicity of Hepatitis B Virus Vaccine (Heptavax-B)—Response of Healthy Adults
We vaccinated 30 healthy adults who were susceptible to hepatitis B virus with 20 μg of Merck Sharp & Dohme vaccine at zero, one and six months and measured their antibody (anti-HBs) response weekly for four weeks and monthly for at least seven months. A month following the first dose 40% had an...
Na minha lista:
| Main Authors: | , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
1984
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1011077/ https://ncbi.nlm.nih.gov/pubmed/6233795 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|